Wikidata

(Q66403825)

English

Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant

clinical trial

In more languages

Statements

title
Phase II Trial of Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in High Risk AML Patients Who Are Not Eligible for Allogeneic Stem Cell Transplantation (English)
0 references
start time
28 September 2016
0 references
end time
30 June 2020
0 references
number of participants
20
0 references
research intervention
pembrolizumab
0 references
fludarabine phosphate
0 references
melphalan
0 references
minimum age
18 year
0 references
maximum age
78 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66403825&oldid=1858893862"